Pancreatic Cancer Research

ResearcherGerman Cancer Research CenterActive in the last 2 years

Bernhard Küster

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-9094-1677; OpenAlex author ID A5058082024. Sources: OpenAlex.

Their work

Papers
7 (first author 0, last author 1)
Trials
0
Grants
0
Labs led
0
Collaborators
50
Papers, trials and grants by year

2012: 1 paper · 2013: none · 2014: none · 2015: none · 2016: none · 2017: none · 2018: none · 2019: none · 2020: 1 paper · 2021: none · 2022: 2 papers · 2023: none · 2024: 1 paper · 2025: 2 papers

Papers 7

  1. Gemcitabine and ATR inhibitors synergize to kill PDAC cells by blocking DNA damage response. Last author DOI 10.1038/s44320-025-00085-6↗
  2. Label-free single-cell phenotyping to determine tumor cell heterogeneity in pancreatic cancer in real time. Co-author DOI 10.1172/jci.insight.169105↗
  3. A Novel AMPK Inhibitor Sensitizes Pancreatic Cancer Cells to Ferroptosis Induction. Co-author DOI 10.1002/advs.202307695↗
  4. Selective multi-kinase inhibition sensitizes mesenchymal pancreatic cancer to immune checkpoint blockade by remodeling the tumor microenvironment. Co-author DOI 10.1038/s43018-021-00326-1↗
  5. Epigenetic drug screening defines a PRMT5 inhibitor-sensitive pancreatic cancer subtype. Co-author DOI 10.1172/jci.insight.151353↗
  6. Radiosensitization by Kinase Inhibition Revealed by Phosphoproteomic Analysis of Pancreatic Cancer Cells. Co-author DOI 10.1074/mcp.ra120.002046↗
  7. MALDI imaging mass spectrometry for in situ proteomic analysis of preneoplastic lesions in pancreatic cancer. Co-author DOI 10.1371/journal.pone.0039424↗

Closest collaborators

The 25 strongest of 50 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Maximilian Reichert · 5 shared papers, 2022–2025 · strength 0.73
  2. Günter Schneider · 5 shared papers, 2020–2025 · strength 0.63
  3. Roland Rad · 4 shared papers, 2022–2025 · strength 0.52
  4. Dieter Saur · 4 shared papers, 2022–2025 · strength 0.52
  5. Felix Orben · 3 shared papers, 2022–2025 · strength 0.42
  6. Roland Michael Schmid · 4 shared papers, 2012–2025 · strength 0.42
  7. Stefanie Höfer · 2 shared papers, 2024–2025 · strength 0.35
  8. Christian Schneeweis · 3 shared papers, 2022–2024 · strength 0.35
  9. Aristeidis Papargyriou · 2 shared papers, 2024–2025 · strength 0.31
  10. Stefanie Bärthel · 2 shared papers, 2022–2025 · strength 0.27
  11. Lukas Krauß · 2 shared papers, 2022–2024 · strength 0.25
  12. Carolin Schneider · 2 shared papers, 2022–2024 · strength 0.25
  13. Matthias Wirth · 2 shared papers, 2022–2024 · strength 0.25
  14. Chiara Falcomatà · 2 shared papers, 2022–2024 · strength 0.24
  15. Jens Thomas Siveke · 2 shared papers, 2012–2025 · strength 0.24
  16. Hendrik Schürmann · 1 shared paper, 2025 · strength 0.21
  17. Valentina Leone · 1 shared paper, 2025 · strength 0.21
  18. Katja Wittenzellner · 1 shared paper, 2025 · strength 0.17
  19. Daniele Lucarelli · 1 shared paper, 2025 · strength 0.17
  20. H. Carlo Maurer · 1 shared paper, 2025 · strength 0.17
  21. Helmut Friess · 1 shared paper, 2025 · strength 0.17
  22. İhsan Ekin Demir · 1 shared paper, 2025 · strength 0.17
  23. Michael B. Ghadimi · 1 shared paper, 2024 · strength 0.14
  24. Marian Grade · 1 shared paper, 2024 · strength 0.14
  25. Constanza Tapia Contreras · 1 shared paper, 2024 · strength 0.14

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.